AP1530A - Pharmaceutical composition for intramuscular injection containing loxoprofen. - Google Patents

Pharmaceutical composition for intramuscular injection containing loxoprofen.

Info

Publication number
AP1530A
AP1530A APAP/P/2002/002594A AP2002002594A AP1530A AP 1530 A AP1530 A AP 1530A AP 2002002594 A AP2002002594 A AP 2002002594A AP 1530 A AP1530 A AP 1530A
Authority
AP
ARIPO
Prior art keywords
intramuscular injection
pharmaceutical composition
injection containing
containing loxoprofen
loxoprofen
Prior art date
Application number
APAP/P/2002/002594A
Other versions
AP2002002594A0 (en
Inventor
Sung-Tae Lee
Shin Han
Woo-Yle Park
Chul-Kyu Lee
Hey-Sea Kim
Original Assignee
Shin Poong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co Ltd filed Critical Shin Poong Pharmaceutical Co Ltd
Publication of AP2002002594A0 publication Critical patent/AP2002002594A0/en
Application granted granted Critical
Publication of AP1530A publication Critical patent/AP1530A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a formulation for intramuscular injection containing loxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect, as an active ingredient.
APAP/P/2002/002594A 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen. AP1530A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (en) 2000-12-14 2000-12-14 Pharmaceutical composition for intramuscular injection containing loxoprofen
PCT/KR2001/002161 WO2002047661A1 (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen

Publications (2)

Publication Number Publication Date
AP2002002594A0 AP2002002594A0 (en) 2002-09-30
AP1530A true AP1530A (en) 2006-01-04

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002594A AP1530A (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen.

Country Status (12)

Country Link
JP (1) JP2004515526A (en)
KR (1) KR100405161B1 (en)
CN (1) CN1278672C (en)
AP (1) AP1530A (en)
AR (1) AR033596A1 (en)
AU (1) AU2002222750A1 (en)
BR (1) BR0108313A (en)
MX (1) MXPA02007788A (en)
OA (1) OA12175A (en)
RU (1) RU2232572C2 (en)
UA (1) UA76097C2 (en)
WO (1) WO2002047661A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
SI1615646T2 (en) 2003-04-08 2022-11-30 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
WO2009031577A1 (en) 2007-09-04 2009-03-12 Meiji Seika Kaisha, Ltd. Injection, injection solution and injection kit preparation
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
JP2011225514A (en) * 2009-10-30 2011-11-10 Kowa Co Pharmaceutical composition containing loxoprofen or salt thereof
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
EP2939666A1 (en) 2014-04-29 2015-11-04 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EA201692424A1 (en) 2014-06-30 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. COMBINATION OF LOXOPROPHENE AND AGONIST OF GAMMA-AMINOIL ACID RECEPTORS
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740374A (en) * 1985-11-26 1988-04-26 Nitto Electric Industrial Co., Ltd. Anti-inflammatory analgesic adhesive preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10120560A (en) * 1996-08-26 1998-05-12 Sankyo Co Ltd Loxoprofen-containing preparation for external use
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740374A (en) * 1985-11-26 1988-04-26 Nitto Electric Industrial Co., Ltd. Anti-inflammatory analgesic adhesive preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUGEMOTO ET AL.: 'Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-sodium, an anti-inflammatory prodrug' BIOCHEM. PHARMCOL. vol. 42, no. 12, 1991, pages 2363 - 2368 *

Also Published As

Publication number Publication date
JP2004515526A (en) 2004-05-27
AU2002222750A1 (en) 2002-06-24
MXPA02007788A (en) 2002-10-17
UA76097C2 (en) 2006-07-17
CN1400892A (en) 2003-03-05
OA12175A (en) 2006-05-09
WO2002047661A1 (en) 2002-06-20
AP2002002594A0 (en) 2002-09-30
AR033596A1 (en) 2003-12-26
CN1278672C (en) 2006-10-11
RU2232572C2 (en) 2004-07-20
KR100405161B1 (en) 2003-11-12
BR0108313A (en) 2003-03-11
KR20020046407A (en) 2002-06-21

Similar Documents

Publication Publication Date Title
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
AU2001260414A1 (en) Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
WO2002015903A3 (en) Novel pharmaceutical composition for administering n-0923
TW200503685A (en) A pharmaceutical composition for inhibiting coronavirus
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
MXPA04011528A (en) Topically applicable pharmaceutical preparation.
WO1999055332A8 (en) Medicinal compositions
BG66093B1 (en) Controlled release compositions comprising nimesulide
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
AU3850600A (en) Dalda analogs and their use
DE60019334D1 (en) ANTIVIRAL ARZNEI
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
AP2003002763A0 (en) Controlled release formulations for oral administration
CA2386793A1 (en) New selective retinoid agonists
AP1530A (en) Pharmaceutical composition for intramuscular injection containing loxoprofen.
DK1383540T3 (en) Methods and pharmaceutical compositions for wound healing
SE0102440D0 (en) New compound
SE9900070D0 (en) New use
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
CA2402707A1 (en) Use of cdp-choline for the treatment of alcohol withdrawal syndrome
ECSP055804A (en) PHARMACEUTICAL COMPOSITION
CA2499620A1 (en) External preparation containing acetylsalicylic acid for inhibiting keloid formation
NZ521515A (en) Composition comprising paracetamol and niflumic acid
ATE259802T1 (en) COMPOUNDS WITH ANTITHROMBOTIC ACTION